Deutsche Bank Cuts ViroPharma (VPHM) to Hold; Takeout Premium Reflected in Price
Tweet Send to a Friend
Deutsche Bank downgraded ViroPharma (NASDAQ: VPHM) from Buy to Hold with a price target of $43.00 (from $38.00). Analyst Robyn ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
